Curmeric- Safety-Efficacy- Community-Quarantine-COVID-19

Not Applicable

• Conditions: COVID-19; SARS-CoV2; Nidovirales Infections; Coronaviridae Infections; Coronavirus Infections; SARS Virus; Disease Prevention; Betacoronavirus

• Registration Number: RPCEC00000351
• Lead Sponsor: Center for Technological Applications and Nuclear Development (CEADEN)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-22
• Study Completion: 2021-03-01
• Results First Posted: 2021-04-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 340

Inclusion Criteria

Inhabitants of the area in quarantine because of COVID-19 in primary health care.

Exclusion Criteria

Known allergy to Turmeric.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of positive cases for COVID-19 (Number of positive patients). Measurement time: A month after inclusion

Secondary Outcome Measures

Name	Time	Method
Adverse Events-AE (Occurrence of AE (Yes, No); Type of event (name of AE); Intensity of AE (Mild, Moderate, Severe); Result (Recovered, Not recovered, Recovered with sequelae, Death); Required treatment (Yes, No)). Measurement time: A month after inclusion